P-wave Duration and Dispersion in Intrahepatic Cholestasis of Pregnancy
Recruitment status was Recruiting
Intrahepatic Cholestasis of Pregnancy
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
- change in the range of P-wave Duration and Dispersion [ Time Frame: one year ] [ Designated as safety issue: No ]A 12-lead surface ECG will obtain for all pregnants with icp in the supine position after a rest period of 10 minutes. Two consecutive cycles will record at a speed of 50 mm/sec and with an amplitude of 10mm/mV. All ECGs will examine by a designated cardiologist blinded to patient details. To improve accuracy, measurements will made using calipers and magnifying lens. Only participants with normal sinus rhythm on ECG will include in the final analysis
|Study Start Date:||July 2013|
|Estimated Study Completion Date:||June 2014|
|Estimated Primary Completion Date:||May 2014 (Final data collection date for primary outcome measure)|
pregnant with ICP
pregnant with ICP
Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disease. The most frequent laboratory abnormality is elevation of serum bile acid levels in ICP.
Bile acids increases both maternal and fetal circulation in ICP. The bile acids has been demonstrated to cause arrhythmia and abnormal calcium dynamics in cultured neonatal rat cardiomyocytes. Raised maternal bile acid levels have been associated with fetal distress and arrhytmia in fetus.
P-wave dispersion (PWD) is defined as the difference between the maximum and the minimum P-wave durations measured on a 12-lead surface electrocardiogram (ECG). Increased P-wave duration and PWD have been reported in various clinical settings, including atrial flutter, coronary artery disease, hypertension, rheumatic mitral stenosis, mitral annular calcification, obstructive sleep apnea, and obesity.
So the investigators think that bile acids may alter maternal cardiomyocyte function as fetus. The investigators hypothesized that PWD and p wave duration may affect in pregnancy with ICP.
The aim of this study is to investigate maternal P-wave duration and dispersion changes in pregnant women with intrahepatic cholestasis of pregnancy .
Please refer to this study by its ClinicalTrials.gov identifier: NCT01906827
|Contact: ayse kirbas, md||533 646 92 email@example.com|
|Contact: ozgur kirbas, md||505 799 18 firstname.lastname@example.org|
|Zekai Tahir Burak Maternity Teaching Hospital||Recruiting|
|Contact: ayse kirbas, md 533 646 92 13 email@example.com|
|Contact: ozgur kirbas, md 505 7991823|
|Principal Investigator: ayse kirbas, md|
|Principal Investigator:||ayse kirbas, md||Zekai Tahir Burak Women's Health Research and Education Hospital|
|Principal Investigator:||ozgur kirbas, md||Yuksek Ihtisas Hospital|